Eliem Therapeutics Inc. (ELYM)
NASDAQ: ELYM
· Real-Time Price · USD
5.11
-0.05 (-0.97%)
At close: Oct 02, 2024, 10:00 PM
Eliem Therapeutics Ratios and Metrics
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
PE Ratio | -3.34 | -3.62 | -9.59 | -0.97 | -11.4 | -5.14 | -4.49 | -3.6 | -0.91 | -4.05 | -2.2 | -1.28 | -4.15 | -6.5 | -7.29 | -10.69 | -2.49 |
PEG Ratio | 0.02 | 0.01 | 0.10 | -0.00 | 0.22 | 0.39 | 0.21 | 0.05 | -0.00 | 0.11 | 0.06 | -0.08 | -0.15 | 0.18 | -0.11 | 0.14 | -0.1 |
PS Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 1.43 | 0.93 | 1.56 | 0.96 | 0.73 | 0.70 | 0.65 | 0.67 | 0.66 | 0.75 | 0.63 | 0.56 | 1.42 | 1.64 | 1.59 | 3.66 | 3.74 |
P/FCF Ratio | -17.96 | -16.32 | -45.15 | -320.79 | -42.54 | -78.97 | 20.40 | -9.44 | -5.06 | -11.46 | -20.37 | -5.69 | -20.42 | -34.79 | -21.61 | -43.98 | -27.51 |
P/OCF Ratio | -17.96 | -16.32 | -45.15 | -320.79 | -42.54 | -78.97 | 20.40 | -9.44 | -5.06 | -11.46 | -20.37 | -5.69 | -20.42 | -34.79 | -21.61 | -43.98 | -27.51 |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.01 | n/a | n/a | n/a | n/a |
Quick Ratio | 14.25 | 31.41 | 57.73 | 60.41 | 36.70 | 38.92 | 37.90 | 30.44 | 23.72 | 23.11 | 20.42 | 17.06 | 19.01 | 25.66 | 27.55 | 17.94 | 12.54 |
Current Ratio | 14.25 | 31.41 | 57.73 | 60.41 | 36.70 | 38.92 | 38.76 | 31.58 | 22.25 | 22.04 | 21.21 | 17.48 | 19.33 | 24.58 | 28.38 | 18.34 | 12.91 |
Asset Turnover | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | n/a | 60.26 | n/a | n/a | n/a | -4.46 | n/a | n/a | n/a | n/a | n/a | -8.33 | -57.34 | n/a | n/a | n/a | n/a |
Return on Equity | -0.11 | -0.06 | -0.04 | -0.25 | -0.02 | -0.03 | -0.04 | -0.05 | -0.18 | -0.05 | -0.07 | -0.11 | -0.09 | -0.06 | -0.05 | -0.09 | -0.37 |
Return on Assets | -0.1 | -0.06 | -0.04 | -0.24 | -0.02 | -0.03 | -0.04 | -0.04 | -0.17 | -0.04 | -0.07 | -0.1 | -0.08 | -0.06 | -0.05 | -0.08 | -0.35 |
Return on Invested Capital | -0.12 | -0.4 | -0.05 | -0.02 | -0.03 | -0.05 | -0.05 | -0.06 | -0.19 | -0.06 | -0.06 | -0.1 | -0.08 | -0.06 | -0.05 | -0.09 | -0.14 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 0.03 | n/a | 0.02 | n/a | 0.01 | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -0.14 | n/a | -0.43 | n/a | -0.25 | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |